Fig. 3From: The number of methylated CpG sites within the MGMT promoter region linearly correlates with outcome in glioblastoma receiving alkylating agents(a) Fitted probabilities according to the stratified Cox proportional hazards model of overall survival (OS) for 215 glioblastoma patients with regard to the cumulative number [n] of ‘methylated’ CpG sites (violet: n = 25, light blue: n = 20, blue: n = 15, red: n = 10, green: n = 5, orange: n = 0). (b) Kaplan–Meier curves of overall survival for 113 glioblastoma patients with MSP-positive tumors (dotted blue line) substratified for the cumulative number [n] of ‘methylated’ CpG sites (light blue line: n ≥ 18, dark blue line: n < 18)Back to article page